MarketPeel
Insider Trading Intelligence
VM

Vimal Mehta

BTAI
CEO AND PRESIDENT · BIOXCEL THERAPEUTICS, INC. · CIK 0001733369
FILING MIX · LIFETIME41%/59%
BUYS
46
SELLS
65
TOTAL VALUE
$42.56M
COMPANIES
1
ACTIVE SINCE
Mar 2018
HOLDINGS NOW
69,817
AVG SELL PX
$26.70
TRADE KIND
SHOWING 111 / 111
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
29 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Vimal Mehta, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d29+79.31%-6.47%+0.05%-6.52%-7.74%
14d29+72.41%-18.87%+1.28%-20.15%-6.99%
30d29+65.52%-10.26%+3.05%-13.31%-12.76%
60d29+65.52%-18.33%+3.24%-21.57%-40.44%
90d29+79.31%-42.38%+4.83%-47.20%-58.72%
180d29+93.10%-67.96%+10.18%-78.15%-88.57%
1y29+100.00%-87.64%+20.56%-108.20%-108.35%
2y29(4 pending)+100.00%-97.87%+45.17%-143.48%-142.66%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BTAI · 69,817 shares · as of Jun 15, 2026
02,295,0004,590,0006,885,0009,180,00020192020202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2018
2018
2018
2018
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 46 buys / 65 sellsCOVERAGE · 34 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
21969,817Jun 15, 2026Jun 17, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2191,313Jun 15, 2026Jun 17, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,419$1.09$21.1K69,598May 20, 2026May 22, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
49,75889,017May 4, 2026May 22, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
49,758149,274May 4, 2026May 22, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
18,00039,259May 1, 2026May 7, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
18,0000May 1, 2026May 7, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2191,532Mar 15, 2026Mar 16, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
21921,259Mar 15, 2026Mar 16, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
164488Mar 14, 2026Mar 16, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
16421,040Mar 14, 2026Mar 16, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
199,032200,783Jan 1, 2026Jan 5, 2026View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
21920,876Dec 15, 2025Dec 15, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2191,751Dec 15, 2025Dec 15, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
164652Dec 14, 2025Dec 15, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
16420,657Dec 14, 2025Dec 15, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
21920,493Sep 15, 2025Sep 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2191,970Sep 15, 2025Sep 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
163816Sep 14, 2025Sep 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
16320,274Sep 14, 2025Sep 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
18,00018,000Aug 1, 2025Aug 5, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,62520,111Jul 22, 2025Jul 22, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2192,189Jun 15, 2025Jun 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2194,486Jun 15, 2025Jun 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
163979Jun 14, 2025Jun 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
1634,267Jun 14, 2025Jun 16, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2172,408Mar 15, 2025Mar 17, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2174,104Mar 15, 2025Mar 17, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
1621,142Mar 14, 2025Mar 17, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
1623,887Mar 14, 2025Mar 17, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
660,000660,000Jan 7, 2025Jan 10, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
983$0.36$35860,920Dec 16, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,134$0.36$77359,605Dec 16, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
3,50061,903Dec 15, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
3,50031,500Dec 15, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,61058,403Dec 14, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,61013,049Dec 14, 2024Dec 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,150$0.69$79451,666Sep 16, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
832$0.69$57352,816Sep 16, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
3,50035,000Sep 15, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
3,50053,648Sep 15, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,60950,148Sep 14, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,60915,657Sep 14, 2024Sep 17, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,2506,250Jul 22, 2024Apr 1, 2025View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,134$1.28$2.7K47,539Jun 17, 2024Jun 18, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
3,50049,673Jun 15, 2024Jun 18, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
3,50038,500Jun 15, 2024Jun 18, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,60918,266Jun 14, 2024Jun 18, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,60946,173Jun 14, 2024Jun 18, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
283,1220Jun 5, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
126,014$1.58$199.6K7,685,501Jun 5, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
609,2217,937,529Jun 4, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
283,123283,122Jun 4, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
126,014$1.63$205.5K7,811,515Jun 4, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
120120Jun 4, 2024Jun 6, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
829$2.62$2.2K48,003Apr 4, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,439$2.62$11.7K43,564Apr 4, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
14,00048,832Mar 15, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
14,00042,000Mar 15, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,61020,875Mar 14, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,61034,832Mar 14, 2024Apr 8, 2024View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,60932,222Dec 14, 2023Dec 18, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,60923,485Dec 14, 2023Dec 18, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,61029,613Sep 14, 2023Sep 18, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,61026,094Sep 14, 2023Sep 18, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000294,000Jun 16, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
747$21.89$16.4K39,903Jun 16, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,266$20.90$89.2K40,650Jun 16, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K69,903Jun 16, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
24,987$20.01$500.0K44,916Jun 16, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
21,988$21.41$470.8K47,915Jun 15, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,012$21.90$175.5K39,903Jun 15, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000324,000Jun 15, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K69,903Jun 15, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
2,60939,903Jun 14, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
2,60928,704Jun 14, 2023Jun 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,500$25.79$167.6K37,294May 22, 2023May 24, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
15,0000May 14, 2023May 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
15,00030,894May 14, 2023May 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
900$20.15$18.1K15,894Mar 21, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000354,000Mar 21, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
29,100$19.70$573.3K16,794Mar 21, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K45,894Mar 21, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K50,394Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
3,896$18.22$71.0K16,498Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000384,000Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
5,333$18.86$100.6K20,394Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
24,667$18.20$448.9K25,727Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
604$18.88$11.4K15,894Mar 20, 2023Mar 22, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
56,00056,000Mar 15, 2023Mar 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
168,000168,000Mar 15, 2023Mar 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
10,43731,313Mar 14, 2023Mar 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
10,43720,394Mar 14, 2023Mar 16, 2023View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K39,957Dec 16, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
20,113$19.21$386.4K19,844Dec 16, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000414,000Dec 16, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
9,887$19.92$196.9K9,957Dec 16, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
30,000444,000Dec 15, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
22,794$19.86$452.7K17,163Dec 15, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO and President
30,000$0.41$12.3K39,957Dec 15, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO and President
7,206$20.19$145.5K9,957Dec 15, 2022Dec 19, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000May 14, 2022May 17, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
167,000167,000Mar 14, 2022Mar 16, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
41,75041,750Mar 14, 2022Mar 16, 2022View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO, President and Secretary
473,250$30.83$14.59M8,546,750Jun 25, 2021Jun 29, 2021View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Mar 25, 2021Mar 29, 2021View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO, President and Secretary
80,000$60.76$4.86M80,000Jul 24, 2020Feb 16, 2021View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO, President and Secretary
160,000$60.76$9.72M9,020,000Jul 24, 2020Feb 16, 2021View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000250,000May 26, 2020May 28, 2020View →
BTAI
BIOXCEL THERAPEUTICS, INC.
SALE
CEO, President and Secretary
300,000$30.08$9.02M9,180,000Feb 24, 2020May 13, 2020View →
BTAI
BIOXCEL THERAPEUTICS, INC.
PURCHASE
CEO, President and Secretary
2,000$11.00$22.0K2,000Mar 12, 2018Feb 16, 2021View →
Other insiders · BTAI
Loading peer insiders…
About this filer
CIK 0001733369
ROLE
CEO and President
PRIMARY
BTAI
COMPANIES
1
ACTIVE SINCE
Mar 2018
MARKETPEEL · /INSIDER/0001733369DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback